arrow
A

Alessandra Scamporrino

University of Catania
H指数:18
被引数:906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of baseline LDL-C and Lp(a) levels on PCSK9-targeting therapy efficacy in subjects with familial hypercholesterolemia: real-world data from a tertiary lipid center.

基线LDL-C和Lp(a)水平对家族性高胆固醇血症患者PCSK9靶向治疗效果的影响:来自三级血脂中心的真实世界数据

2026-10-150
OAAI
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Steatosis to Systemic Metabolic Failure: Classical Pathophysiology, Emerging Systemic Mechanisms and Modifiable Lifestyle Determinants

代谢功能障碍相关脂肪性肝病(MASLD):从脂肪变性到系统性代谢衰竭:经典病理生理学、新兴系统性机制和可改变的生活方式决定因素

2026-07-230
OA
Impairment of Regenerative and Metabolic Pathways in Intestinal Organoids From Patients With MASLD-Cirrhosis

MASLD肝硬化患者肠道类器官中再生和代谢通路的损害

2025-09-100
PRE
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis

评估家族性高胆固醇血症伴或不伴亚临床动脉粥样硬化的受试者的代谢和先天免疫谱

2025-02-010
OAAI
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy

急性高胆红素血症决定了早期的亚临床肾损害: 对胆汁性肾病肾小管生物标志物的评估

2024-06-041
OAAI
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia

SLCO1B1 rs4149056对男性和女性家族性高胆固醇血症患者降脂治疗优化后ldl-c目标实现的影响

2024-02-087
OAAI
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease

2型糖尿病和非白蛋白尿糖尿病肾病患者的心血管风险和肾损伤概况

2023-12-137
OAAI
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia

家族性高胆固醇血症患者高密度脂蛋白结合长链非编码rna的评价

2023-08-129
OA
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes

糖尿病前期血小板反应性和促炎性特征增加与内膜中层厚度和动脉僵硬度相关

2022-05-193
OAAI
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: A single lipid center real-world experience
2021-03-0139
PRE
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity
2019-06-2652
OAAI